Cefuroxime Axetil Tablet
Cefuroxime Axetil Tablet

Cefuroxime Axetil Tablet

Buyer Feedback
Posted by : Mr Nitin Y Bhide
Last updated on : Mar 13,2019
Product added on : Mar 12,2019
Product Code : 1461
Brand Name : CEFAKIND 500 MG
Send Inquiry Have a question?   Ask Supplier
Trade Information
Main Domestic MarketAll India
Sample PolicyContact us for information regarding our sample policy
Payment TermsOthers, Cheque, Cash in Advance (CID)
Supply Ability1000 Per Day
CertificationsISO 9001 TO 20015
Main Export Market(s)Africa, Middle East, Western Europe, Eastern Europe, South America, North America, Central America, Australia, Asia
Delivery Time20 Days
Product Description
Cefuroxime Axetil Tablet are used to treat fungal infections of the toenails. Itraconazole oral solution (liquid) is used to treat yeast infections of the mouth and throat or of the esophagus (tube that connects the throat to the stomach). Itraconazole is in a class of antifungals called triazoles.
About the Supplier

Established in 2016, YOGESHWARI MEDICALS has been a leading name in offering top notch Anti Infective Drugs & Medicines. Located in Mumbai, Maharashtra, we offer the best quality Cefuroxime Axetil Tablet to our customers at best prices in the industry.

  • Nature of Business
    Exporter / Wholesaler/Distributor / Supplier / Trading Company
  • Number of Employees
  • Year of Establishment
  • Annual Turnover
    Rs 0 Lakhs
  • Standard Certification
    ISO 2009-2015
Send your inquiry directly to this supplierReceiver's Company Name: YOGESHWARI MEDICALS

* Tips on getting accurate quotes. Please include product name, order quantity, usage, special requests if any in your inquiry.

Send this inquiry to other Suppliers of similar products (?)
I agree to abide by all the Terms and Conditions of tradeindia.com
Contact Details
Inside Jeevan Vikas Kendra’s, Sadanand Danait Hospital, Jeevan Vikas Road, Koldongri, Andheri East,
Mumbai, Maharashtra, 400069, India
Contact Supplier
Mr Nitin Y Bhide
Mr Nitin Y BhidePartner
Last updated on : 22 March 2019 Report Incorrect Contact